银屑病关节炎中是否需要具有新型作用机制的新型药物？ - Suppr

Is there a need for new agents with novel mechanisms of action in psoriatic arthritis?

作者信息

Orr Carl, Veale Douglas James

机构信息

Dublin Academic Medical Centre, Centre for Arthritis and Rheumatic Diseases, St Vincent's University Hospital and The Conway Institute of Biomolecular and Biomedical Research, University College Dublin, , Dublin, Ireland.

出版信息

Ann Rheum Dis. 2014 Jun;73(6):951-3. doi: 10.1136/annrheumdis-2013-204934.

DOI:10.1136/annrheumdis-2013-204934

PMID:24790066

Abstract

摘要

相似文献

Is there a need for new agents with novel mechanisms of action in psoriatic arthritis?

Ann Rheum Dis. 2014 Jun;73(6):951-3. doi: 10.1136/annrheumdis-2013-204934.

Biological and synthetic target DMARDs in psoriatic arthritis.

Pharmacol Res. 2019 Nov;149:104473. doi: 10.1016/j.phrs.2019.104473. Epub 2019 Oct 1.

[Update in treatment of psoriatic arthritis].

Tunis Med. 2008 Dec;86(12):1036-41.

Psoriatic arthritis.

Joint Bone Spine. 2005 Dec;72(6):466-70. doi: 10.1016/j.jbspin.2005.10.006. Epub 2005 Oct 25.

Combination of antitumour necrosis factor-α and anti-interleukin-12/23 antibodies in refractory psoriasis and psoriatic arthritis: a long-term case-series observational study.

Br J Dermatol. 2016 May;174(5):1145-6. doi: 10.1111/bjd.14270. Epub 2016 May 4.

Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial.

Ann Rheum Dis. 2014 Jun;73(6):990-9. doi: 10.1136/annrheumdis-2013-204655. Epub 2014 Jan 30.

Therapy: Ustekinumab after anti-TNF failure: a step closer to the PSUMMIT of psoriatic arthritis therapy?

Nat Rev Rheumatol. 2014 Mar;10(3):125. doi: 10.1038/nrrheum.2014.24. Epub 2014 Feb 18.

[New drugs and treatment strategies for rheumatoid arthritis].

Recenti Prog Med. 2003 Sep;94(9):361-79.

Bone anabolic changes progress in psoriatic arthritis patients despite treatment with methotrexate or tumour necrosis factor inhibitors.

Ann Rheum Dis. 2013 Jul;72(7):1176-81. doi: 10.1136/annrheumdis-2012-201580. Epub 2012 Aug 21.

Biologic agents for treating ankylosing spondylitis: beyond TNFα antagonists.

Joint Bone Spine. 2011 Dec;78(6):542-4. doi: 10.1016/j.jbspin.2011.05.023. Epub 2011 Jul 30.

引用本文的文献

Inflammatory Cytokines in Psoriatic Arthritis: Understanding Pathogenesis and Implications for Treatment.

Int J Mol Sci. 2023 Jul 19;24(14):11662. doi: 10.3390/ijms241411662.

Targeted Therapies in Psoriatic Arthritis-An Update.

Int J Mol Sci. 2023 Mar 28;24(7):6384. doi: 10.3390/ijms24076384.

JAK1 selective inhibitors for the treatment of spondyloarthropathies.

Rheumatology (Oxford). 2021 May 5;60(Suppl 2):ii39-ii44. doi: 10.1093/rheumatology/keaa815.

An Overview of Bimekizumab for the Treatment of Psoriatic Arthritis: The Evidence so Far.

Drug Des Devel Ther. 2021 Mar 9;15:1045-1053. doi: 10.2147/DDDT.S267405. eCollection 2021.

The rationale for Janus kinase inhibitors for the treatment of spondyloarthritis.

Rheumatology (Oxford). 2019 Feb 1;58(2):197-205. doi: 10.1093/rheumatology/key070.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Is there a need for new agents with novel mechanisms of action in psoriatic arthritis?

作者信息

Orr Carl, Veale Douglas James

机构信息

出版信息

Ann Rheum Dis. 2014 Jun;73(6):951-3. doi: 10.1136/annrheumdis-2013-204934.

DOI:10.1136/annrheumdis-2013-204934

PMID:24790066

Abstract

摘要

相似文献

Is there a need for new agents with novel mechanisms of action in psoriatic arthritis?

Ann Rheum Dis. 2014 Jun;73(6):951-3. doi: 10.1136/annrheumdis-2013-204934.

Biological and synthetic target DMARDs in psoriatic arthritis.

Pharmacol Res. 2019 Nov;149:104473. doi: 10.1016/j.phrs.2019.104473. Epub 2019 Oct 1.

[Update in treatment of psoriatic arthritis].

Tunis Med. 2008 Dec;86(12):1036-41.

Psoriatic arthritis.

Joint Bone Spine. 2005 Dec;72(6):466-70. doi: 10.1016/j.jbspin.2005.10.006. Epub 2005 Oct 25.

Combination of antitumour necrosis factor-α and anti-interleukin-12/23 antibodies in refractory psoriasis and psoriatic arthritis: a long-term case-series observational study.

Br J Dermatol. 2016 May;174(5):1145-6. doi: 10.1111/bjd.14270. Epub 2016 May 4.

Ann Rheum Dis. 2014 Jun;73(6):990-9. doi: 10.1136/annrheumdis-2013-204655. Epub 2014 Jan 30.

Therapy: Ustekinumab after anti-TNF failure: a step closer to the PSUMMIT of psoriatic arthritis therapy?

Nat Rev Rheumatol. 2014 Mar;10(3):125. doi: 10.1038/nrrheum.2014.24. Epub 2014 Feb 18.

[New drugs and treatment strategies for rheumatoid arthritis].

Recenti Prog Med. 2003 Sep;94(9):361-79.

Bone anabolic changes progress in psoriatic arthritis patients despite treatment with methotrexate or tumour necrosis factor inhibitors.

Ann Rheum Dis. 2013 Jul;72(7):1176-81. doi: 10.1136/annrheumdis-2012-201580. Epub 2012 Aug 21.

Biologic agents for treating ankylosing spondylitis: beyond TNFα antagonists.

Joint Bone Spine. 2011 Dec;78(6):542-4. doi: 10.1016/j.jbspin.2011.05.023. Epub 2011 Jul 30.

引用本文的文献

Inflammatory Cytokines in Psoriatic Arthritis: Understanding Pathogenesis and Implications for Treatment.

Int J Mol Sci. 2023 Jul 19;24(14):11662. doi: 10.3390/ijms241411662.

Targeted Therapies in Psoriatic Arthritis-An Update.

Int J Mol Sci. 2023 Mar 28;24(7):6384. doi: 10.3390/ijms24076384.

JAK1 selective inhibitors for the treatment of spondyloarthropathies.

Rheumatology (Oxford). 2021 May 5;60(Suppl 2):ii39-ii44. doi: 10.1093/rheumatology/keaa815.

An Overview of Bimekizumab for the Treatment of Psoriatic Arthritis: The Evidence so Far.

Drug Des Devel Ther. 2021 Mar 9;15:1045-1053. doi: 10.2147/DDDT.S267405. eCollection 2021.

The rationale for Janus kinase inhibitors for the treatment of spondyloarthritis.

Rheumatology (Oxford). 2019 Feb 1;58(2):197-205. doi: 10.1093/rheumatology/key070.

Is there a need for new agents with novel mechanisms of action in psoriatic arthritis?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Is there a need for new agents with novel mechanisms of action in psoriatic arthritis?

作者信息

机构信息

出版信息

相似文献

引用本文的文献